Keyu Yue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Keyu Yue has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Jie Shen
Department of Clinical Examination, Taixing People’s Hospital, 1 Changzheng Rd, Taixing, Jiangsu 225400, China
1 shared publication - Kejing Zhu
Organ Transplantation Department, The Affiliated Hospital of Guizhou Medical University
1 shared publication - Liying Zhu
School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou 550004, PR China; Center for Clinical Laboratories, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, PR China
1 shared publication - Qing Wu
Innovation Laboratory, The Third Experiment Middle School, Guizhou Key Laboratory for Information System of Mountainous Areas and Protection of Ecological Environment, Guizhou Normal University, 116 Baoshan North Rd, Guiyang, Guizhou 550001, China
1 shared publication - Wei Pan
Prenatal Diagnosis Center in Guizhou Province, The Affiliated Hospital of Guizhou Medical University, Guizhou, Guiyang, China
1 shared publication - Wen Xu
Guizhou Prenatal Diagnosis Center, The Affiliated Hospital of Guizhou Medical University, 28 Guiyi Rd, Guiyang, Guizhou 550004, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by Wiley in International Journal of Intelligent Systems
- Vol. 2023 (1)
Application of Serum Mid‐Infrared Spectroscopy Combined with Machine Learning in Rapid Screening of Breast Cancer and Lung Cancer
Cancer is an increasing burden on global health. Breast and lung cancers are the two tumors with the highest incidence rates. The study shows that early detection and early diagnosis are important prognostic factors for breast and lung cancers. Due to the great advantages of artificial intelligence in feature extraction, the combination of infrared analysis technology may have great potential in clinical applications. This study explores the potential application of mid‐infrared spectroscopy combined with machine learning for the differentiation of breast and lung cancers. The experiment collects blood samples from clinical sources, separates serum, trains classification models, and finally predicts unknown sample categories. We use k‐fold cross‐validation to determine the training set of 301 cases and the test set of 50 cases. Through differential spectrum analysis, we found that the intervals of 1318.59–1401.03 cm−1, 1492.15–1583.27 cm−1, and 1597.25–1721.64 cm−1 have significant differences, which may reflect the absorption of key chemical bonds in protein molecules. We use a total of 24 models such as decision trees, discriminant analysis, support vector machines, and K‐nearest neighbor to train, identify, and distinguish spectra. The results show that under the same conditions, the prediction model trained based on fine KNN has the best performance and can perform 100% prediction on the test set samples. This also shows that our model has important potential for auxiliary diagnosis of serum breast cancer and lung cancer. This method may help to further achieve comprehensive screening of associated cancers in underserved areas, thereby reducing the cancer burden through early detection of cancer and appropriate treatment and care of cancer patients.
- 1 January 2023
- Published by Wiley in International Journal of Intelligent Systems
- Vol. 2023 (1)
Open AccessApplication of Serum Mid‐Infrared Spectroscopy Combined with Machine Learning in Rapid Screening of Breast Cancer and Lung Cancer
Cancer is an increasing burden on global health. Breast and lung cancers are the two tumors with the highest incidence rates. The study shows that early detection and early diagnosis are important prognostic factors for breast and lung cancers. Due to the great advantages of artificial intelligence in feature extraction, the combination of infrared analysis technology may have great potential in clinical applications. This study explores the potential application of mid‐infrared spectroscopy combined with machine learning for the differentiation of breast and lung cancers. The experiment collects blood samples from clinical sources, separates serum, trains classification models, and finally predicts unknown sample categories. We use k‐fold cross‐validation to determine the training set of 301 cases and the test set of 50 cases. Through differential spectrum analysis, we found that the intervals of 1318.59–1401.03 cm−1, 1492.15–1583.27 cm−1, and 1597.25–1721.64 cm−1 have significant differences, which may reflect the absorption of key chemical bonds in protein molecules. We use a total of 24 models such as decision trees, discriminant analysis, support vector machines, and K‐nearest neighbor to train, identify, and distinguish spectra. The results show that under the same conditions, the prediction model trained based on fine KNN has the best performance and can perform 100% prediction on the test set samples. This also shows that our model has important potential for auxiliary diagnosis of serum breast cancer and lung cancer. This method may help to further achieve comprehensive screening of associated cancers in underserved areas, thereby reducing the cancer burden through early detection of cancer and appropriate treatment and care of cancer patients.